Abstract
Seaweed-derived polysaccharides with unique structural and functional entities have gained special research attention in the current medical sector. Seaweed polysaccharides have been or being used to engineer novel cues with biomedical values to tackle in practice the limitations of counterparts which have become ineffective for 21st-century settings. The inherited features of seaweed polysaccharides, such as those of a biologically tunable, biocompatible, biodegradable, renewable, and non-toxic nature, urge researchers to use them to design therapeutically effective, efficient, controlled delivery, patient-compliant, and age-compliant drug delivery platforms. Based on their significant retention capabilities, tunable active units, swelling, and colloidal features, seaweed polysaccharides have appeared as highly useful materials for modulating drug-delivery and tissue-engineering systems. This paper presents a standard methodological approach to review the literature using inclusion-exclusion criteria, which is mostly ignored in the reported literature. Following that, numerous marine-based seaweed polysaccharides are discussed with suitable examples. For the applied perspectives, part of the review is focused on the biomedical values, i.e., targeted drug delivery, wound-curative potential, anticancer potentialities, tissue-engineering aspects, and ultraviolet (UV) protectant potential of seaweed polysaccharides based engineered cues. Finally, current challenges, gaps, and future perspectives have been included in this review.
Highlights
Over the past four decades, the biomedical sector at large and drug-delivery platforms in particular, have witnessed significant advancements in this domain of the 21st-century world
Part of the review is focused on the biomedical values, i.e., targeted drug delivery, wound-curative potential, anticancer potentialities, tissue-engineering aspects, and ultraviolet (UV) protectant potential of seaweed polysaccharides based engineered cues
Considering the best match terms, i.e., marine seaweed polysaccharides, drug delivery, wound healing, and anticancer activities of polysaccharides and polysaccharide-based engineered carriers, seaweed polysaccharides, drug delivery, wound healing, and anticancer activities of polysaccharides and polysaccharide-based engineered carriers, the inclusion-exclusion criteria were applied for initial screening
Summary
Over the past four decades, the biomedical sector at large and drug-delivery platforms in particular, have witnessed significant advancements in this domain of the 21st-century world Throughout this venture, research scientists, both from the academia and industrial sector, have revisited and adapted their efforts and focus on (re)searching and engineering materials and cues/carriers with potentialities to meet the rising demands of medical and health care settings. Aiming to ensure the safety and overall effectiveness, new engineered cues using naturally-occurring seaweed polysaccharides with inherited biomedical values are being developed and exploited as a combinational approach This is because the seaweed polysaccharides based engineered carriers can overcome the aforementioned challenges. Biomedical potentialities of marine-based seaweed polysaccharides, i.e., carrageenan, fucoidans, alginate,alginate, agar, agarose, laminaran, and furcellaran.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
